For media inquiries, contact Paul Williams at media@capillarybio.com or +1 (310) 569-0023.
News
Press Releases
Scientific Presentations
August 14, 2018
Capillary Biomedical Closes
$2.9 Million Series Seed Financing for Commercialization of Novel Insulin Infusion Technology
November 9, 2018
“Histological Comparison of Tissue Response to Investigational and Commercially-Available Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine” presented at Diabetes Technology Society’s 18th Annual Meeting
June 22, 2018
“Micro-CT Imaging of an Insulin Bolus Infusion Through Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine: Quantitative Comparison of Distribution Patterns in Tissue Over Eight Days.” presented at ADA’s 78th Scientific Sessions
June 13, 2017
Capillary Biomedical Sheds Light on the Mechanical Challenges of Insulin Pump Delivery Systems at Annual ADA Scientific Sessions
February 14, 2018
“Histological Comparison of Tissue Response for Stainless Steel and Teflon Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine” presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes
June 13, 2017
“Micro-CT Imaging of an Insulin Bolus Infusion Through Commercial Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine: A Time Course Study of Distribution Patterns” presented at ADA’s 77th Scientific Sessions
August 3, 2016
Capillary Biomedical Developing Improved Insulin Delivery Catheter with Funding Support from JDRF
July 6, 2016
“Tissue Histology Surrounding Continuous Subcutaneous Insulin Infusion (CSII) Catheters Implanted in Canines for 7 Days” presented at NIH’s Fourth Artificial Pancreas Workshop
October 22, 2015
“Optimization of Insulin Delivery through a CSII Catheter” presented at 15th Annual Diabetes Technology Meeting
28 Days Agoview on linkedin
Don't be content with infusion site failures! That was the message from Paul Strasma, President & CEO, in this interview at the T1D Exchange Diabetes Innovation Challenge. https://lnkd.in/gkdUwhf
OC Startups Now interviewed Capillary Biomedical Director Howard Mirowitz about the Cove Fund's investment. https://lnkd.in/gXKjCiB
OC Startups Now interviewed Capillary Biomedical Director and Cove Fund Manager Howard Mirowitz. https://lnkd.in/gXKjCiB
Omar Ford interviewed Capillary Biomedical CEO Paul Strasma for Qmed's MD+DI daily's article Building a Better Insulin Infusion System.
Pleased to officially announce our Series Seed Financing! Thank you to our new investors from the Cove Fund, New York Angels, Tech Coast Angels, Pasadena Angels, HBS Alumni Angels and Mass Medical Angels.
CEO Paul Strasma will be presenting our kink-proof infusion set at the 2018 Diabetes Innovation Challenge Finals this May 21st in Boston. https://lnkd.in/gjp_v5v
Proud to be a finalist in the T1D Exchange Diabetes Innovation Challenge! Learn more at https://lnkd.in/gT32ECR then cast your vote for our "Kink-proof Infusion" entry.
Honored to be selected as semi-finalists in the Diabetes Innovation Challenge by T1D Exchange! Register and vote for our Kink-Proof Infusion entry at https://lnkd.in/ggQSkb9
Tim Street of Diabettech.com provides an excellent background story on prior research into sprinkler needles for insulin delivery. https://lnkd.in/g6K26rp
LinkedIn Company Updates
